The regulation of the Nrf2 pathway by dexamethasone (Dex) has been confirmed by other scholars [14], but whether the underlying mechanism of its effective treatment of COPD is to interfere with pyroptosis by inhibiting NLRP3 remains to be explored. Here, NLRP3 is linked to chronic obstructive pulmonary disease.